Want to join the conversation?
$MHK 2Q15 PR: Net sales were $2.0Bil, flat vs. 2Q14 or a 7% increase on a constant currency exchange rate basis. Net earnings were $186MM and diluted EPS was $2.53. Excluding unusual charges, net earnings were $199MM and EPS was $2.69, a 22% increase over 2Q14 adjusted EPS.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.